Clinical trials
Thyroid clinical trials
Below are recruiting thyroid clinical trials, each written for real people, not researchers. We’re tracking 324 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06927375RecruitingPhase 4
Combination drug therapy for thyroid eye disease
This study tests a combination of two drugs, tocilizumab and flupentixol-melitracen, in people with active, moderate-to-severe thyroid-associated eye disease (TED). It aims to see if this combination can reduce eye bulging, double vision, and anxiety symptoms.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07173621Enrolling by invitation
Comparing a wound-healing gel to standard care after thyroid or parathyroid surgery
This study compares a special wound-healing gel (called AMNIOEFFECT) with standard care after thyroid or parathyroid surgery. The goal is to see if the gel helps your incision heal better.
Sarasota, FloridaAges 18 years+ - NCT07142005Recruiting
Educational tool for Hispanic medullary thyroid cancer patients
This study tests a culturally tailored educational tool to help Hispanic or Latino/a patients with medullary thyroid cancer and their caregivers make informed decisions. It aims to improve understanding and support for Spanish-speaking individuals.
Houston, TexasAges 18 years+ - NCT07124572Recruiting
Building a Better Diagnosis System for Thyroid Eye Disease
This study aims to build a better system for diagnosing and treating thyroid-associated ophthalmopathy (a thyroid eye condition). It may help improve care for people with this disease, and also involves healthy volunteers as a comparison group.
Hangzhou, ZhejiangAges 7–90 - NCT07113262RecruitingPhase 3
Study of IBI311 for people with inactive thyroid eye disease
This trial tests a new medication called IBI311 for people whose thyroid eye disease is no longer active but still causes bulging eyes. It aims to see if the drug can reduce eye bulging safely.
Shenyang, LiaoningAges 18–80 - NCT07102264Recruiting
Ultrasound test for thyroid stiffness before surgery
This study tests a new, non-invasive ultrasound method to measure how compressible (squishy) your thyroid gland is, before you have surgery to remove it. The goal is to see if this safe, painless measurement can help surgeons plan better.
BernAges 18 years+ - NCT07059507Recruiting
Thyroid cancer in Graves' disease patients having thyroid surgery
This study looks at how often thyroid cancer is found by accident in people with Graves' disease who have their thyroid removed. It helps doctors understand who might be at higher risk so they can plan better care.
Minya, Minya GovernorateAges 18–75 - NCT07041307Recruiting
Study of blood flow in thyroid nodules before surgery
This trial uses a special imaging technique to look at the tiny blood vessels inside thyroid nodules before they are removed. It may help doctors understand which nodules are cancerous.
CopenhagenAges 18 years+ - NCT07033572Recruiting
Hybrid scope surgery and ablation for both sides of thyroid cancer
This study tests a combined approach—removing the main thyroid cancer with a tiny camera (endoscope) and using targeted heat to destroy a small nodule on the opposite side. It aims to treat both sides of the thyroid at once with less scarring and faster recovery.
Fuzhou, FujianAges 18–65 - NCT07022236Recruiting
Thyroid Function in Hemodialysis Patients
This study checks thyroid function in people who are on long-term hemodialysis for kidney failure. It aims to see how common thyroid issues are in this group, which could help improve care.
SohagAges 13–80 - NCT06849284Recruiting
Predicting thyroid nodule results with a new test
This study tests a new tool (ThyroidPrint) to see if it can accurately predict whether a thyroid nodule with unclear biopsy results is benign or malignant. The goal is to help doctors and patients decide on surgery more confidently.
Truro, CornwallAges 18 years+ - NCT06984991Recruiting
Why some thyroid biopsy samples are hard to evaluate quickly
This trial looks at what makes it harder to quickly tell if a thyroid nodule sample is good enough for diagnosis during your biopsy. It may help doctors improve the procedure for people with suspicious nodules.
Asyut, Asyut GovernorateAges 18 years+ - NCT06980103Recruiting
Decision aid for RAI in thyroid cancer
This trial offers a decision aid to help you choose whether to have radioactive iodine (RAI) treatment after thyroid cancer surgery. You may qualify if you have intermediate-risk thyroid cancer and haven't yet made a decision about RAI.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06970353RecruitingPhase 2
Study of tunlametinib for NRAS-mutant advanced thyroid cancer
This trial tests a targeted drug (tunlametinib) for advanced thyroid cancer that has a specific genetic change called NRAS mutation. It may help people whose cancer is not responding to standard treatments like radioactive iodine.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06959511RecruitingPhase 2
Zanzalintinib for advanced thyroid cancer before surgery
This trial tests a drug called zanzalintinib for people with advanced thyroid cancer that has spread nearby. The goal is to see if taking this pill before surgery can shrink the tumor and make it easier to remove.
Ann Arbor, MichiganAges 18 years+ - NCT06961084RecruitingPhase 2
I-124 PET/CT scan for diagnosing thyroid cancer
This trial tests whether a new type of scan (I-124 PET/CT) can better detect thyroid cancer compared to standard scans. It may help doctors decide on the best treatment, such as radiation therapy or surgery.
San Francisco, CaliforniaAges 13 years+ - NCT06923826RecruitingPhase 2
Study of sacituzumab govitecan for advanced salivary gland and thyroid cancers
This trial tests a drug called sacituzumab govitecan in people with advanced salivary gland cancer or thyroid cancer that has spread or cannot be removed. The goal is to see if the drug can help shrink or slow down the cancer.
SingaporeAges 21 years+ - NCT06860971RecruitingPhase 3
AL2846 capsule vs placebo for advanced thyroid cancer
This study tests a new oral capsule (AL2846) against a placebo in people with advanced thyroid cancer that no longer responds to radioactive iodine. The goal is to see if AL2846 can slow or stop cancer growth.
Hefei, AnhuiAges 18–75 - NCT06853925Recruiting
Online program for thyroid cancer symptom management
This study tests a web-based program to help people with thyroid cancer manage symptoms from radioactive iodine (RAI) treatment and improve their quality of life. It is for those who have had RAI within the past three years and are experiencing mild to moderate symptoms.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06852144Enrolling by invitation
PET-CT scan for thyroid and parathyroid evaluation
This study looks at how well PET-CT scans can find thyroid or parathyroid problems. The trial uses scans that are already part of your regular care to learn more about these conditions.
Bologna, BoAges 18 years+ - NCT06796348Recruiting
Needle treatment vs surgery for small thyroid cancers
This study compares a non-surgical procedure (radiofrequency ablation) with partial thyroid removal (hemithyroidectomy) for treating small thyroid cancers. It aims to find out if the needle-based treatment is as effective as surgery, with fewer side effects.
AarhusAges 30 years+ - NCT06765941Recruiting
PTeye vs surgeon's eyes for parathyroid protection in thyroid surgery
This trial tests whether a device called PTeye helps surgeons better identify and protect the parathyroid glands during first-time total thyroid removal surgery, compared to relying on the surgeon's eyes alone.
Krakow, MałopolskaAges 18 years+ - NCT06736015Recruiting
Myo-inositol and Selenium for Indeterminate Thyroid Nodules
This trial tests whether taking myo-inositol and selenium supplements can help reduce the risk of thyroid cancer in people with thyroid nodules that are considered 'indeterminate' (TIR3a). The goal is to see if these supplements can prevent the nodules from becoming cancerous.
RomeAges 18 years+ - NCT05752604Recruiting
Study of treatments and factors in thyroid cancer
This study looks at thyroid cancer and how standard treatments and other health details relate to outcomes. You might be eligible if you have thyroid cancer and can participate by giving informed consent.
MilanAges Any age
Hear when a new Thyroid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for thyroid?
- Yes. Clin2 currently lists 324 recruiting thyroid studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a thyroid trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a thyroid trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.